Position in REGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$11,263,003
-$2,654,561 QoQ
Shares Held
18,063
+0.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#272
of 1,297 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $117,820,260 across 121 Biotechnology names. REGN ranks #2 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
|
39,368 | $2,756,941 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,263,003 | 18,063 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $13,917,564 | 18,013 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,068,959 | 15,636 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,588,111 | 15,274 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,329,125 | 15,865 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,317,019 | 16,267 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $11,591,033 | 16,272 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,599,079 | 15,790 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $16,292,016 | 15,501 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,946,507 | 15,529 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $12,626,297 | 14,376 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $11,129,711 | 13,524 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $10,480,624 | 14,586 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $12,638,106 | 15,381 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $10,785,554 | 14,949 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $8,907,777 | 12,931 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $7,347,154 | 12,429 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $9,360,224 | 13,402 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $8,336,064 | 13,200 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,850,155 | 6,362 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $3,811,476 | 6,824 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $6,886,552 | 14,555 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $7,050,990 | 14,595 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,125,954 | 21,662 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $14,439,368 | 23,153 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||